Analytical Cellular Pathology (Jan 2018)

Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas

  • Ramón G. Carreón-Burciaga,
  • Rogelio González-González,
  • Nelly Molina-Frechero,
  • Sandra López-Verdín,
  • Vanesa Pereira-Prado,
  • Ronell Bologna-Molina

DOI
https://doi.org/10.1155/2018/9392632
Journal volume & issue
Vol. 2018

Abstract

Read online

Ameloblastomas are a group of benign, locally aggressive, recurrent tumors characterized by their slow and infiltrative growth. E-Cadherin and syndecan-1 are cell adhesion molecules related to the behavior of various tumors, including ameloblastomas. Ninety-nine ameloblastoma samples were studied; the expression of E-cadherin and syndecan-1 were evaluated by immunohistochemistry. E-Cadherin and epithelial syndecan-1 were more highly expressed in intraluminal/luminal unicystic ameloblastoma than in mural unicystic ameloblastoma and solid/multicystic ameloblastoma, whereas the stromal expression of syndecan-1 was higher in mural unicystic ameloblastoma and solid/multicystic ameloblastoma. Synchronicity was observed between E-cadherin and epithelial syndecan-1; the expression was correlated with intensity in all cases. There was a strong association between expression and tumor size and recurrence. The evaluation of the expression of E-cadherin and syndecan-1 are important for determining the potential aggressiveness of ameloblastoma variants. Future studies are required to understand how the expression of these markers is related to tumor aggressiveness.